Discontinuation report TEVA-OXYBUTYNIN

Last updated on 2024-10-11 History
Report ID 240078
Drug Identification Number 02230394
Brand name TEVA-OXYBUTYNIN
Common or Proper name OXYBUTININ 5mg
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) OXYBUTYNIN CHLORIDE
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500
ATC code G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2024-09-06
Actual discontinuation date 2024-09-06
Remaining supply date 2024-09-06
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2024-10-11 French Compare
v1 2024-10-11 English Compare

Showing 1 to 2 of 2